Projected Growth of the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market to Reach $1.83 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical contract development and manufacturing organization (cmo) market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market By The End Of 2029?

The transfection technologies market has shown strong growth in recent years. It is anticipated to expand from $1.21 billion in 2024 to $1.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.3%. This historic growth is largely attributable to the increasing prevalence of chronic diseases, the expanded applications of transfection technologies, the growing demand for cell & gene therapy, increasing R&D investments, and rising cancer incidences.

The transfection technologies market is projected to experience substantial expansion over the coming years, reaching $1.83 billion by 2029, with an anticipated compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period is primarily driven by factors such as the increasing prevalence of chronic and immunological conditions, the escalating demand for cell-based therapies, a surge in protein production requirements, heightened investments and financial backing for developing drug delivery systems, and the growing need for monoclonal antibodies. Key trends anticipated in this period encompass heightened research and development efforts in cell-based therapies, the integration of technologically sophisticated transfection methods, an escalating requirement for advanced therapeutic delivery solutions, increased utilization of dual-reporter assays and co-transfection experiments, and an intensifying emphasis on personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Business Drivers Are Underpinning The Growth Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

The increasing adoption of gene therapy is anticipated to fuel the expansion of the transfection technologies market in the future. Gene therapy represents an approach designed to address or avert illnesses through gene manipulation, specifically involving the introduction, mending, or substitution of defective genes. The ascent of gene therapy is fueled by advancements in genetic research, improved delivery techniques, and its capacity to address genetic disorders that were previously untreatable. Transfection technologies play a vital role in gene therapy, enabling the accurate, secure, and efficient transfer of genetic material into cellular structures. These technologies enable both transient and lasting alterations to the genome, which are fundamental for managing genetic ailments and malignancies. As an illustration, in July 2023, a report from the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, indicated that by the close of the first quarter (Q1) of 2023, 247 gene therapies were in Phase II. This figure saw a 5% increase, reaching 260 by the end of the second quarter (Q2). Consequently, the expanding use of gene therapy is propelling the expansion of the transfection technologies market.

What Are The Principal Segment Types In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are Industry Trends Steering The Expansion Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

Leading companies within the transfection technologies market are prioritizing the development of advanced solutions, such as mechanoporation transfection systems, to enable more intricate and tailored applications in both research and therapeutic contexts. Mechanoporation transfection systems function by employing mechanical forces to create transient pores in cell membranes, thereby allowing genetic material to enter cells. This approach is highly efficient and minimally invasive, leading to improved cell viability. As an illustration, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system consists of a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Leveraging controlled, rapid deformation within microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, while ensuring minimal cellular disruption and high viability. These characteristics are crucial for advancing research and fostering the creation of cutting-edge cell and gene therapies.

Which Companies Are Contributing Significantly To The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Growth?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Offers The Most Opportunity For Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Expansion?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2025, By The Business Research Company

Transfection Reagents And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

5G Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/5g-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info